We’re proud to share that Potter Clarkson has once again been ranked among the world’s leading patent firms in the IAM Patent 1000: The World’s Leading Patent Professionals 2025.
On 1 January 2025, a new and modernised Swedish Patent Act entered into force, replacing the Patent Act from 1967.
Formula 1 is on the cusp of a significant transformation, with the sport considering drastic changes for its next set of engine regulations. Ethan Silverstone, patent attorney and former F1 engineer, considers the strategic IP decisions going on behind the scenes.
Following its previous widely-reported ruling earlier this year, the Mannheim Local Division has now issued its decision in respect of the UK aspect of the infringement proceedings brought by FujiFilm, marking the first time that the UPC has granted an injunction which applies to the UK.
Space agriculture (or as you may know it, space-based AgTech, astroagriculture, exo-agriculture, off-earth farming or extraterrestrial food systems) refers to agricultural technologies and systems developed or tested in space.
Potter Clarkson unveils the most comprehensive Synthetic Biology Patent Landscape Report, created in collaboration with Inevus Advanced Analytics and using the most comprehensive patent database, provided by Questel.
Gene editing technologies like CRISPR and RNA interference (RNAi) are revolutionising agriculture.
A Board of Appeal at the EPO has referred questions to the Enlarged Board of Appeal (EBA) in connection with inconsistencies between the claims and description of a European patent vs. those of a European patent application (pre-grant vs. post-grant).
In the recent decision Generics v AstraZeneca, the UK Court of Appeal confirmed that the UK’s approach to ‘plausibility’ remains unchanged despite the EPO Enlarged Board of Appeal decision G2/21.
In April 2023, the European Commission adopted a comprehensive package of proposed reforms to the legislation governing the authorisation of medicines in the EU.
The revamped UPC Case Management System (‘CMS’) is now live. The objective of the new CMS is to simplify access for users. This will be a welcome update for IP practitioners who have in the past experienced various issues when using the old CMS.
The implementation of the Windsor Framework on 1 January 2025 marked a significant turning point in the UK’s regulatory landscape for human medicines. Among the most consequential changes are those affecting the legal basis and procedural requirements for Supplementary Protection Certificates (SPCs) and paediatric extensions.
The Enlarged Board of Appeal of the European Patent Office has issued a landmark decision significantly altering the interpretation of what constitutes prior art.
The launch of the Cali Fund at COP16 marked a new international framework for sharing benefits from Digital Sequence Information (DSI). But while the broad architecture of the Fund has been agreed much remains uncertain for businesses, especially SMEs navigating this evolving landscape.
The Court of Appeal (CoA) confirms the UPC’s jurisdiction over infringements committed before 1 June 2023 and during an opt-out period where the European patent is subsequently opted back into the jurisdiction of the UPC.